The global healthcare and pharmaceutical landscape is witnessing increasing interest in serotonin receptor targeted therapeutics due to their expanding role in neurological and psychiatric disease management. Advances in receptor biology, precision medicine, and neuropharmacology are creating new growth avenues for therapies associated with 5-hydroxytryptamine receptors. The growing prevalence...